AC
GSK icon

Ascend Capital’s GSK GSK Stock Holding History

Ascend Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-560,000
Closed -$28.2M – 119
2015
Q4 		$28.2M Buy
560,000
+80,000
+17% +$4.08M 0.99% 30
2015
Q3 		$23.1M Buy
480,000
+312,880
+187% +$16.3M 0.9% 40
2015
Q2 		$8.7M Buy
+167,120
New +$9.41M 0.29% 101
2015
Q1 		– Sell
-424,720
Closed -$22.7M – 187
2014
Q4 		$22.7M Buy
+424,720
New +$23.8M 0.87% 42

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ascend Capital's GSK Position: Q1 2015 in Review

Ascend Capital sold out of GSK (GSK) in Q1 2015, closing a stake of 322,417 shares — an estimated $17.2M sold.

Ascend Capital first reported a position in GSK in Q3 2014 and held it in 2 quarters. The position peaked at $17.2M in Q4 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Ascend Capital reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • Ascend Capital sold 322,417 GSK shares in Q1 2015, an estimated $17.2M.
  • Ascend Capital first reported a position in GSK in Q3 2014 and held it in 2 quarters.
  • Ascend Capital's GSK position peaked at $17.2M in Q4 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Ascend Capital's 13F filing for Q1 2015, filed 14 May 2015.